microBrain™ is Back for Your Drug Discovery Needs!

Speaker: AxoSim’s Newest Scientists Andrew LaCroix, PhD and Nicholas Coungeris | AxoSim Co-Founder and CEO J. Lowry Curley, PhD

Join us for a webinar: Functional screening on microBrain™ organoids and their applications to neuromodulation studies and disease modeling. With AxoSim’s acquisition of Vyant Bio’s StemoniX assets, the microBrain™ technology is back for your neuroscience preclinical research. Learn about the acquisition, this cutting edge technology and meet the talented scientists working exclusively with the platform.